Zoekresultaten - Mark H. Wilcox

Verfijn jouw resultaten
  1. 1
    Overcoming barriers to effective recognition and diagnosis of Clostridium difficile infection

    Overcoming barriers to effective recognition and diagnosis of Clostridium difficile infection door Mark H. Wilcox

    Gepubliceerd in 2012
    Volledige tekst Volledige tekst
    Revisão
    Toevoegen aan favorieten
    Bewaard in:
  2. 2
    Long-term surveillance of cefotaxime and piperacillin-tazobactam prescribing and incidence of Clostridium difficile diarrhoea

    Long-term surveillance of cefotaxime and piperacillin-tazobactam prescribing and incidence of Clostridium difficile diarrhoea door Mark H. Wilcox

    Gepubliceerd in 2004
    Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  3. 3
    Treatment of Clostridium difficile infection

    Treatment of Clostridium difficile infection door Mark H. Wilcox

    Gepubliceerd in 1998
    Volledige tekst Volledige tekst
    Revisão
    Toevoegen aan favorieten
    Bewaard in:
  4. 4
    Descriptive study of intravenous immunoglobulin for the treatment of recurrent Clostridium difficile diarrhoea

    Descriptive study of intravenous immunoglobulin for the treatment of recurrent Clostridium difficile diarrhoea door Mark H. Wilcox

    Gepubliceerd in 2004
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  5. 5
    New and emerging therapies for Clostridium difficile infection

    New and emerging therapies for Clostridium difficile infection door Jessica Martin, Mark H. Wilcox

    Gepubliceerd in 2016
    Volledige tekst
    Revisão
    Toevoegen aan favorieten
    Bewaard in:
  6. 6
    Antimicrobial Resistance and Reduced Susceptibility in Clostridium difficile: Potential Consequences for Induction, Treatment, and Recurrence of C. difficile Infection

    Antimicrobial Resistance and Reduced Susceptibility in Clostridium difficile: Potential Consequences for Induction, Treatment, and Recurrence of C. difficile Infection door Simon D. Baines, Mark H. Wilcox

    Gepubliceerd in 2015
    Volledige tekst Volledige tekst
    Revisão
    Toevoegen aan favorieten
    Bewaard in:
  7. 7
    Molecular epidemiology of endemic <i>Clostridium difficile</i> infection

    Molecular epidemiology of endemic <i>Clostridium difficile</i> infection door Warren N. Fawley, Mark H. Wilcox

    Gepubliceerd in 2001
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  8. 8
    Clostridium difficile infection: epidemiology, diagnosis and understanding transmission

    Clostridium difficile infection: epidemiology, diagnosis and understanding transmission door Jessica Martin, Tanya Monaghan, Mark H. Wilcox

    Gepubliceerd in 2016
    Volledige tekst
    Revisão
    Toevoegen aan favorieten
    Bewaard in:
  9. 9
    Models for the study of Clostridium difficile infection

    Models for the study of Clostridium difficile infection door Emma L. Best, Jane Freeman, Mark H. Wilcox

    Gepubliceerd in 2012
    Volledige tekst Volledige tekst
    Revisão
    Toevoegen aan favorieten
    Bewaard in:
  10. 10
    The slime of coagulase-negative staphylococci: Biochemistry and relation to adherence

    The slime of coagulase-negative staphylococci: Biochemistry and relation to adherence door Muzaffar Hussain, Mark H. Wilcox, Peter J White

    Gepubliceerd in 1993
    Volledige tekst Volledige tekst
    Revisão
    Toevoegen aan favorieten
    Bewaard in:
  11. 11
    Effects of piperacillin/tazobactam on Clostridium difficile growth and toxin production in a human gut model

    Effects of piperacillin/tazobactam on Clostridium difficile growth and toxin production in a human gut model door Simon D. Baines, Jane Freeman, Mark H. Wilcox

    Gepubliceerd in 2005
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  12. 12
    Comparative Analysis of Prevalence, Risk Factors, and Molecular Epidemiology of Antibiotic-Associated Diarrhea Due to <i>Clostridium difficile</i> , <i>Clostridium perfringens</i> , and <i>Staphylococcus aureus</i>

    Comparative Analysis of Prevalence, Risk Factors, and Molecular Epidemiology of Antibiotic-Associated Diarrhea Due to <i>Clostridium difficile</i> , <i>Clostridium perfringens</i>... door N. J. Asha, D S Tompkins, Mark H. Wilcox

    Gepubliceerd in 2006
    Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  13. 13
    The Efficacy and Safety of Fecal Microbiota Transplant for Recurrent Clostridiumdifficile Infection: Current Understanding and Gap Analysis

    The Efficacy and Safety of Fecal Microbiota Transplant for Recurrent Clostridiumdifficile Infection: Current Understanding and Gap Analysis door Mark H. Wilcox, Barbara McGovern, Gail Hecht

    Gepubliceerd in 2020
    Volledige tekst Volledige tekst
    Revisão
    Toevoegen aan favorieten
    Bewaard in:
  14. 14
    Clostridioides difficile infection: are the three currently used antibiotic treatment options equal from pharmacological and microbiological points of view?

    Clostridioides difficile infection: are the three currently used antibiotic treatment options equal from pharmacological and microbiological points of view? door Marcela Krůtová, Mark H. Wilcox, Ed J. Kuijper

    Gepubliceerd in 2022
    Volledige tekst Volledige tekst
    Revisão
    Toevoegen aan favorieten
    Bewaard in:
  15. 15
    Comparison of Nine Commercially Available <i>Clostridium difficile</i> Toxin Detection Assays, a Real-Time PCR Assay for <i>C</i> . <i>difficile tcdB</i> , and a Glutamate Dehydrogenase Detection Assay to Cytotoxin Testing and Cytotoxigenic Culture Methods

    Comparison of Nine Commercially Available <i>Clostridium difficile</i> Toxin Detection Assays, a Real-Time PCR Assay for <i>C</i> . <i>difficile tcdB</i> , and a Glutamate Dehydrog... door K. Eastwood, Patrick Else, André Charlett, Mark H. Wilcox

    Gepubliceerd in 2009
    Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  16. 16
    Clostridium difficile: A European perspective

    Clostridium difficile: A European perspective door A. M. Jones, Ed J. Kuijper, Mark H. Wilcox

    Gepubliceerd in 2012
    Volledige tekst Volledige tekst
    Revisão
    Toevoegen aan favorieten
    Bewaard in:
  17. 17
    Summary of Ceftaroline Fosamil Clinical Trial Studies and Clinical Safety

    Summary of Ceftaroline Fosamil Clinical Trial Studies and Clinical Safety door Thomas M. File, Mark H. Wilcox, Gary E. Stein

    Gepubliceerd in 2012
    Volledige tekst
    Revisão
    Toevoegen aan favorieten
    Bewaard in:
  18. 18
    Point-Counterpoint: What Is the Optimal Approach for Detection of Clostridium difficile Infection?

    Point-Counterpoint: What Is the Optimal Approach for Detection of Clostridium difficile Infection? door Ferric C. Fang, Christopher R. Polage, Mark H. Wilcox

    Gepubliceerd in 2017
    Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  19. 19
    Comparison of the efficacy of ramoplanin and vancomycin in both in vitro and in vivo models of clindamycin-induced Clostridium difficile infection

    Comparison of the efficacy of ramoplanin and vancomycin in both in vitro and in vivo models of clindamycin-induced Clostridium difficile infection door Jane Freeman, Simon D. Baines, Daniela Jabés, Mark H. Wilcox

    Gepubliceerd in 2005
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  20. 20
    Effect of metronidazole on growth and toxin production by epidemic Clostridium difficile PCR ribotypes 001 and 027 in a human gut model

    Effect of metronidazole on growth and toxin production by epidemic Clostridium difficile PCR ribotypes 001 and 027 in a human gut model door Jane Freeman, Simon D. Baines, Katie Saxton, Mark H. Wilcox

    Gepubliceerd in 2007
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:

Zoekinstrumenten: